Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Marina Biotech and ProNAi Therapeutics enter license agreement for DNAi-based therapies

March 16, 2012

No Comments

FDA approves first effervescent osteoporosis drug

March 15, 2012

No Comments

Amorfix announces new technology acquisition

March 13, 2012

No Comments

New nanovector platform allows noncovalent assembly of targeted therapeutics

March 12, 2012

No Comments

Nuvilex provides information on cell encapsulation technology

March 12, 2012

No Comments

Benitec Biopharma enters into new licensing agreement

March 9, 2012

No Comments

Mersana partners to develop novel antibody-drug conjugates

March 8, 2012

No Comments

First-in-human study of implantable drug delivery microchip succeeds

March 5, 2012

No Comments

Shire and arGEN-X to develop therapeutic antibodies for rare diseases

March 1, 2012

No Comments

Merck & Co. licenses Protein Sciences technology for vaccine research

Feb. 28, 2012

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Drug design, drug delivery and technologies
RSS

Marina Biotech and ProNAi Therapeutics enter license agreement for DNAi-based therapies

FDA approves first effervescent osteoporosis drug

Amorfix announces new technology acquisition

New nanovector platform allows noncovalent assembly of targeted therapeutics

Nuvilex provides information on cell encapsulation technology

Benitec Biopharma enters into new licensing agreement

Mersana partners to develop novel antibody-drug conjugates

First-in-human study of implantable drug delivery microchip succeeds

Shire and arGEN-X to develop therapeutic antibodies for rare diseases

Merck & Co. licenses Protein Sciences technology for vaccine research

Today's news in brief

Today's news in brief

Second insulin receptor offers new therapeutic avenues

Mechanism underlying so-called idiopathic autism inception unveiled

Drug duo to Repare lack in gyno cancers? Phase I shows promise

Drug design, drug delivery and technologies RSS

Drug design, drug delivery and technologies
RSS